GALNT7-TTC29 Fusion FISH Probe
The GALNT7-TTC29 Fusion FISH Probe is used to confirm a fusion of the GALNT7 and TTC29 genes. The fusion of the GALNT7 and TTC29 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GALNT7-TTC29-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GALNT7-TTC29-20-AQAQ | 20 (40 μL) | 200 μL |
|
GALNT7 Gene Summary
This gene encodes GalNAc transferase 7, a member of the GalNAc-transferase family. The enzyme encoded by this gene controls the initiation step of mucin-type O-linked protein glycosylation and transfer of N-acetylgalactosamine to serine and threonine amino acid residues. This enzyme is a type II transmembrane protein and shares common sequence motifs with other family members. Unlike other family members, this enzyme shows exclusive specificity for partially GalNAc-glycosylated acceptor substrates and shows no activity with non-glycosylated peptides. This protein may function as a follow-up enzyme in the initiation step of O-glycosylation. [provided by RefSeq, Jul 2008]
Gene Name: Polypeptide N-acetylgalactosaminyltransferase 7
Chromosome: CHR4: 174089903 -174245118
Locus: 4q34.1
TTC29 Gene Summary
The Tetratricopeptide Repeat Domain 29 (TTC29) gene is located on chr4 :147628178-147867034 at 4q31.22.
Gene Name: Tetratricopeptide Repeat Domain 29
Chromosome: CHR4: 147628178 -147867034
Locus: 4q31.22
Gene Diseases
The GALNT7 TTC29 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|